Help us make a
difference sooner...
The Draigon Consortium proposes to validate and demonstrate the clinical efficacy of
a novel diagnostic test focusing on blood and periprosthetic joint infections at five hospitals in the Netherlands, Austria, Albania and the United States.
The DRAIGON Consortium plans to demonstrate performance for two critical prototype infections, namely bloodstream infections (BSI) and periprosthetic joint infections (PJI).
This diagnostic test will be easy to implement and may also function as an early detection system to prevent cross-border spread of pathogens.
To guide the implementation of the tools developed through DRAIGON, an extensive health technology assessment (HTA) will be performed.
This assessment will consider:
-
Health-economic implications
-
Patient outcomes
-
Social issues
Research Team
Lim Lin Xenia
Camtech
Simon van der Pol
Health-Ecore
Sylvia Debast
Isala
Trish Simner
JHU
Sujeesh Sebastian
OSS
Janine de Zeeuw
UMCG
Roland Martzy
UMCG
Meng Han Kuok
Camtech
Sophie Welk
Health-Ecore
Hendrik Gremmels
Isala
Yehudit Bergman
JHU
Jochen Hofstaetter
OSS
Bhanu Sinha
UMCG
Maria João Cardoso
UMCG
Daniel Kirilly
Camtech
Cornelis Boersma
Health-Ecore
Tim Severs
Isala
Sofia Berdalli
OSS
Susana Hartmann
OSS
Anurag Bari
UMCG
Priscilla Anyimiah
Health-Ecore
Maarten Postma
Health-Ecore
John Rossen
Isala & UMCG
Karina Hackl
OSS
Silva Tafaj
UHSN
Basil Britto Xavier
UMCG
Check the latest news:
Connect on LinkedIn: Join our professional network to connect with like-minded individuals, participate in discussions, and stay abreast of industry trends.
Follow us on X: Connect with us on X for regular updates, insightful articles, and opportunities to engage with our community.
